Amundi Asset Management US’s Allergan plc AGN.PRA Stock Holding History

Amundi Asset Management US’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,275	Closed	-$5.44M	–	1635
2017 Q4	$5.44M	Hold	9,275	–	–	0.01%	822
2017 Q3	$6.84M	Hold	9,275	–	–	0.02%	355
2017 Q2	$8.05M	Hold	9,275	–	–	0.03%	346
2017 Q1	$7.88M	Hold	9,275	–	–	0.03%	337
2016 Q4	$7.07M	Hold	9,275	–	–	0.02%	347
2016 Q3	$7.62M	Hold	9,275	–	–	0.03%	357
2016 Q2	$7.73M	Buy	9,275 +3,200	+53%	+$2.67M	0.03%	338
2016 Q1	$5.58M	Buy	+6,075	New	+$5.81M	0.02%	387

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Amundi Asset Management US's AGN.PRA Position: Q1 2018 in Review

Amundi Asset Management US sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 9,275 shares — an estimated $5.44M sold.

Amundi Asset Management US first reported a position in AGN.PRA in Q1 2016 and held it in 8 quarters. The position peaked at $8.05M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Amundi Asset Management US reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Amundi Asset Management US sold 9,275 Allergan plc shares in Q1 2018, an estimated $5.44M.
Amundi Asset Management US first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
Amundi Asset Management US's Allergan plc position peaked at $8.05M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Amundi Asset Management US's 13F filing for Q1 2018, filed 15 May 2018.